跳至主要内容
临床试验/NCT07370454
NCT07370454已完成不适用

Clinical Evaluation of the Xpert Hemorrhagic Fever Test Using Clinical Specimens and Contrived Samples on the GeneXpert Edge X System

Cepheid1 个研究点 分布在 1 个国家目标入组 408 人开始时间: 2025年1月13日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Cepheid
入组人数
408
试验地点
1
主要终点
Clinical performance comparing Xpert Hemorrhagic Fever to known status of specimens

研究概览

简要总结

A multi-site observation study that was conducted a geographically diverse sites across the United States

详细描述

Capillary and venous whole blood specimens were prospectively collected from consented individuals symptomatic or asymptomatic of fever

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Capillary and venous whole blood specimens from blood donors who symptomatic for fever lasting ≤ 10 days OR asymptomatic for fever
  • Whole blood specimens collected in EDTA specimens collection devices only

排除标准

  • Any whole blood specimens from blood donors vaccinated with a Hemorrhagic Fever live virus vaccine within the past 28 days
  • Any whole blood specimen that were previously enrolled
  • Any whole blood specimens not collected according to the manufacturer's instructions

研究组 & 干预措施

Capillary and venous whole blood specimens

whole blood specimens from individuals asymptomatic or symptomatic of fever

干预措施: Xpert Hemorrhagic Fever test (Diagnostic Test)

结局指标

主要结局

Clinical performance comparing Xpert Hemorrhagic Fever to known status of specimens

时间窗: Clinical Performance assessed in specimens collected at Baseline

Xpert test compared to expected status

次要结局

未报告次要终点

研究者

发起方
Cepheid
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Xpert® Hemorrhagic Fever on the GeneXpert® Edge X... | 临床试验